IMMUNOBIOCHEM CORPORATION
ImmunoBiochem is developing novel tumor microenvironment-targeted biological therapeutics for solid tumor indications.
IMMUNOBIOCHEM CORPORATION
Industry:
Biotechnology Health Care Therapeutics
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.immunobiochem.com
Total Employee:
1+
Status:
Active
Contact:
416.897.2789
Total Funding:
0
Technology used in webpage:
SPF Nginx IPv6 Google Apps For Business Google Google DNS Google Domains Google Cloud DNS
Current Employees Featured
Anton Neschadim CEO @ ImmunoBiochem Corporation
CEO
2015-01-01
Founder
Official Site Inspections
http://www.immunobiochem.com
- Host name: 74-208-236-104.elastic-ssl.ui-r.com
- IP address: 74.208.236.104
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "ImmunoBiochem Corporation"
About - ImmunoBiochem
Jul 24, 2023 About ImmunoBiochem. ImmunoBiochem is an innovative biopharmaceutical company on a mission to develop novel biological therapeutics to address significant unmet …See details»
ImmunoBiochem Corporation - Crunchbase Company …
ImmunoBiochem Corporation closed its last funding round on Dec 11, 2017 from a Seed round. Who are ImmunoBiochem Corporation 's competitors? …See details»
ImmunoBiochem Corporation - LinkedIn
ImmunoBiochem Corporation | 1,487 followers on LinkedIn. Improving patient outcomes through innovations in biological therapeutics | Immunobiochem Corporation is a biotechnology …See details»
ImmunoBiochem Corporation | Source From Ontario
Sep 18, 2024 ImmunoBiochem is an innovative biopharmaceutical company on a mission to develop novel bioconjugate therapeutics to address significant unmet need in oncology, …See details»
Immunobiochem Corporation Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Immunobiochem Corporation of Toronto, ON. Get the latest business insights from Dun & …See details»
ImmunoBiochem Corporation | Source From Ontario
ImmunoBiochem is an innovative biopharmaceutical company on a mission to develop novel bioconjugate therapeutics, such ADCs, ISACs and DACs, to address significant unmet need in …See details»
ImmunoBiochem Corporation - VentureRadar
ImmunoBiochem Corporation is solving the problem of tumor heterogeneity by targeting a novel class of proteins in the tumor microenvironment with Antibody Drug Conjugates (ADCs) – a …See details»
ImmunoBiochem Corporation Announces the …
Dec 11, 2017 ImmunoBiochem is a member of the Ontario Bioscience Innovation Organization (OBIO®) and is partaking in the OBIO Capital Access Advisory Program (CAAP®) – an intensive advisor and investor ...See details»
ImmunoBiochem Company Information - Funding, Investors, and …
Immunobiochem is a biotechnology company that is committed to addressing unmet medical need in oncology via research and development of novel, targeted biological therapeutics. …See details»
ImmunoBiochem Corporation | Source From Ontario
ImmunoBiochem is an innovative, pharma-partnered biotech on a mission to develop novel bioconjugate therapeutics, such as ADCs, ISACs and DACs, to address significant unmet …See details»
ImmunoBiochem 2025 Company Profile: Valuation, Funding
Johnson & Johnson Innovation - JLABS, Ontario Bioscience Innovation Organization, and University of Toronto Entrepreneurship have invested in ImmunoBiochem. Who are …See details»
ImmunoBiochem Corporation | Source From Ontario
ImmunoBiochem is an innovative biopharmaceutical company on a mission to develop novel biological therapeutics to address significant unmet need in oncology and immuno-oncology. …See details»
ImmunoBiochem - UT SpinUp Lab
ImmunoBiochem is on a mission to develop novel bioconjugate therapeutics, such ADCs, ISACs and DACs, to address significant unmet need in oncology, immuno-oncology and immunology. …See details»
ImmunoBiochem Corporation – Funding, Valuation, Investors, News
Immunobiochem Corporation is a biotechnology company committed to addressing unmet medical need in oncology through research and development of novel, targeted biological …See details»
ImmunoBiochem - University of Toronto Entrepreneurship
ImmunoBiochem. Health & Life Sciences Precision Medicine Health Innovation Hub (H2i) ImmunoBiochem is a secretome-focused biotech developing novel tumor microenvironment …See details»
Science – ImmunoBiochem
Jul 24, 2023 ImmunoBiochem has leveraged such novel cancer secretome targets to engender new strategies for the selective and efficacious delivery of potent chemotherapeutic and …See details»
ImmunoBiochem Corporation | Source From Ontario
ImmunoBiochem is an immuno-oncology biopharmaceutical company that has developed a disruptive approach to targeting unique proteins amplified in cancer secretomes. This …See details»
Partnerships with Indigenous Peoples for an ethical bioeconomy
1 day ago The World Health Organization (WHO) reports that approximately 40% of the commercial drugs today derive from plants and Traditional Medicine 3.As biotechnology …See details»
ImmunoBiochem Announces Multi-Target License and Option …
Jul 24, 2023 ImmunoBiochem Press Release <> ImmunoGen Press Release. TORONTO, July 24, 2023 /PRNewswire/ – ImmunoBiochem Corporation, a privately-held biopharmaceutical …See details»
ImmunoBiochem Corporation | Source From Ontario
ImmunoBiochem is an innovative biopharmaceutical company on a mission to develop novel bioconjugate therapeutics, such ADCs, ISACs and DAC. s, to address significant unmet need …See details»